The 2013 edition of Chambers USA: America’s Leading Lawyers for Business has recognized Skadden's REIT practice in the top tier among all law firms nationwide.
Skadden has received the 2013 Chambers USA Award for Excellence for "Employee Benefits & Executive Compensation Team of the Year." The annual award recognizes the nation's top law practices for their outstanding work and excellence in client service.
On the eve of trial, Skadden secured the favorable settlement of a securities class action against Computer Sciences Corp. and certain of its former officers.
Skadden is representing Pfizer Inc. in the split-off of its remaining 80 percent interest in Zoetis Inc. through an exchange offer.
For 13 consecutive years, Skadden has been named the top U.S. corporate law firm in Corporate Board Member magazine’s annual survey of “America’s Best Corporate Law Firms.”
Skadden is representing Theravance Inc. (as co-counsel) in its $1 billion royalty participation agreement with Elan Corporation, plc.
Skadden is representing the underwriters in connection with Fomento Económico Mexicano, S.A.B. de C.V.'s $1 billion placement of two tranches of U.S. dollar-denominated bonds in the international capital markets.
Skadden is representing Central European Distribution Corp. in its prepackaged Chapter 11 reorganization plan.
Rutgers University announced on May 8 that is has retained Skadden to conduct an independent review of its men's basketball program.
Skadden represented Citigroup Global Markets Inc. in connection with a $536.6 million registered underwritten secondary offering of common stock of General Growth Properties, Inc., a Delaware corporation (GGP).